Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

Stopped This study has been terminated because of insufficient patient recruitment.

Conditions

• Uremic Pruritus

Interventions

• DRUG: Nalfurafine hydrochloride(MT-9938) 2.5μg
• DRUG: Nalfurafine hydrochloride(MT-9938) 5μg
• DRUG: Nalfurafine hydrochloride(MT-9938) 10μg
• DRUG: Placebo

Sponsor

Toray Industries, Inc